What is the Optimal Antithrombotic Strategy in Patients Presenting With Acute Coronary Syndrome Having Atrial Fibrillation With Indication for Anticoagulants?
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- 2500
Summary
- Conditions
- Coronary (Artery) Disease
- Acute Coronary Syndrome
- Atrial Fibrillation
- Atrial Flutter
- Bleeding
- Embolism
- Myocardial Infarction
- NSTEMI - Non-ST Segment Elevation MI
- STEMI - ST Elevation Myocardial Infarction
- Stent Thrombosis
- Stroke
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Single (Outcomes Assessor)Primary Purpose: Prevention
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04436978
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Jurriën M ten Berg, MD, PhD St. Antonius Ziekenhuis Nieuwegein, The Netherlands